DEEPNOID Inc.
Financials
Valuation Metrics
DEEPNOID Inc.'s Market Cap is ₩511B. At end of 2025 it was ₩953B. Ranked #1704 of 2,405 in KR market (top 71%), #1030 of 1,627 on KOSDAQ (top 63%), #68 of 94 in Health Care Equipment & Services (top 72%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 51.11B KRW | KR#1,704/2,405 Sec#68/94 |
| Revenue | 4.51B KRW | KR#2,331/2,405 Sec#88/94 |
| Net Income | -14.32B KRW | KR—/2,405 Sec—/94 |
| Total Assets | 32.58B KRW | KR#2,309/2,405 Sec#85/94 |
| Net Assets | 21.37B KRW | KR#2,262/2,405 Sec#84/94 |
| Employees | 170 | KR#1,217/2,405 Sec#38/94 |
| Value | ||
| P/B | 2.39x | KR#2,057/2,405 Sec#72/94 |
| P/S | 11.34x | KR#2,282/2,405 Sec#82/94 |
| FCF Yield | -14.16% | KR—/2,405 Sec—/94 |
| Profitability | ||
| ROE | -67.02% | KR#2,300/2,405 Sec#88/94 |
| ROA | -43.96% | KR#2,339/2,405 Sec#90/94 |
| Op. Margin | -311.32% | KR#2,333/2,405 Sec#88/94 |
| Revenue Growth | -59.93% | KR#2,289/2,405 Sec#90/94 |
| Financial Health | ||
| Debt Ratio | 52.47% | KR#985/2,405 Sec#57/94 |
| Total Debt | 6.66B KRW | KR#1,725/2,405 Sec#57/94 |
| FCF | -7.24B KRW | KR#1,600/2,405 Sec#56/94 |
| Cash | 4.45B KRW | KR#2,042/2,405 Sec#75/94 |
| Current Ratio | 11.26x | KR#82/2,405 Sec#10/94 |
| Performance | ||
| 1Y Return | -58.02% | KR#2,146/2,405 Sec#81/94 |
| 1M Return | -21.27% | KR#1,941/2,405 Sec#84/94 |
| From 52W High | -62.50% | KR#1,776/2,405 Sec#61/94 |
| 1Y MDD | -73.68% | KR#2,103/2,405 Sec#81/94 |
| Trading | ||
| Volume | 30,498 shares | KR#1,270/2,405 Sec#44/94 |
| Trading Value | 52.9M KRW | KR#1,697/2,405 Sec#67/94 |
| Foreign Own. | 2.88% | KR#1,320/2,405 Sec#45/94 |
| Per Share | ||
| EPS | -488 KRW | KR—/2,405 Sec—/94 |
| BPS | 728 KRW | KR#2,343/2,405 Sec#89/94 |
Company Info
DEEPNID, an artificial intelligence company established in 2008, listed on KOSDAQ in 2021 under special provisions for technology growth companies. The company operates businesses providing AI solutions for medical diagnosis and interpretation assistance, early disease diagnosis, X-Ray image automatic interpretation, and deep learning-based vision inspection. Leveraging its medical imaging AI technology, DEEPNID is accelerating market entry through the development of generative AI medical solutions and collaboration with the global leader in machine vision market share. DEEPNID is headquartered in Guro-gu, Seoul.